1190603-51-0 Usage
General Description
2,6-difluoro-3-(methoxymethoxy)benzoic acid is a chemical compound whose molecular formula is C10H8F2O5. It is a white crystalline solid that is sparingly soluble in water. 2,6-difluoro-3-(methoxymethoxy)benzoic acid is used in organic synthesis and has been studied for its potential pharmacological properties, including as a potential anti-inflammatory and anti-cancer agent. Its structure includes a benzene ring with two fluorine atoms at positions 2 and 6, as well as a methoxymethoxy group attached to the benzene ring at position 3. 2,6-difluoro-3-(methoxymethoxy)benzoic acid is a derivative of benzoic acid, a common starting material in the synthesis of various pharmaceuticals and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1190603-51-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,0,6,0 and 3 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1190603-51:
(9*1)+(8*1)+(7*9)+(6*0)+(5*6)+(4*0)+(3*3)+(2*5)+(1*1)=130
130 % 10 = 0
So 1190603-51-0 is a valid CAS Registry Number.
1190603-51-0Relevant articles and documents
A facile approach to the synthesis of 3-(6-Chloro-thiazolo[5,4-b]pyridin-2- ylmethoxy)-2,6-difluoro-benzamide (PC190723)
Ding, Zi-Chun,Zhou, Weicheng,Ma, Xiang
, p. 1039 - 1042 (2012)
Practical synthesis of PC 190723, a bacterial cell division protein Ftsz inhibitor, has been achieved in a high overall yield of 45% in six steps from commercially available starting materials. Georg Thieme Verlag Stuttgart · New York.
P38 MAP KINASE INHIBITORS
-
Page/Page column 55, (2010/07/02)
The present disclosure relates to compounds of formula (I): which are inhibitors of p38 mitogen-activated protein kinase enzymes,particularly the alpha and gamma kinase sub-types thereof, and their use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as COPD
